Cure CMD Congenital Dystroglycanopathies Research Grant
Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.
Eligibility · Global — no geographic restrictions
Cure CMD administers this international research grant under its 2026 Request for Applications for congenital muscular dystrophy. It provides up to USD 50,000 for one or two years of work on congenital-onset alpha-dystroglycanopathies. The funded work can cover the causes of the disease, new treatment targets, gene-based and platform approaches, preclinical testing, disease models, biomarkers and …
Research on congenital dystroglycanopathy disease mechanisms, muscle and brain effects, treatment targets, gene-based approaches, disease models, biomarkers and trial-readiness tools.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up